2023

A preclinical randomized controlled multi-centre trial of anti-interleukin-17A treatment for acute ischaemic stroke
Gelderblom M, Koch S, Strecker J, Jørgensen C, Garcia-Bonilla L, Ludewig P, Schädlich I, Piepke M, Degenhardt K, Bernreuther C, Pinnschmidt H, Arumugam T, Thomalla G, Faber C, Sedlacik J, Gerloff C, Minnerup J, Clausen B, Anrather J, Magnus T
BRAIN COMMUN. 2023;5(2):fcad090.

Clinical Judgment vs Triage Scales for Detecting Large Vessel Occlusions in Suspected Acute Stroke
Schlemm E, Piepke M, Kessner S, Meyer L, Cheng B, Gerloff C, Thomalla G
JAMA NETW OPEN. 2023;6(9):e2332894.

2022

Interleukin-1 Mediates Ischemic Brain Injury via Induction of IL-17A in γδ T Cells and CXCL1 in Astrocytes
Schädlich I, Vienhues J, Jander A, Piepke M, Magnus T, Lambertsen K, Clausen B, Gelderblom M
NEUROMOL MED. 2022;24(4):437-451.

2021

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response
Piepke M, Clausen B, Ludewig P, Vienhues J, Bedke T, Javidi E, Rissiek B, Jank L, Brockmann L, Sandrock I, Degenhardt K, Jander A, Roth V, Schädlich I, Prinz I, Flavell R, Kobayashi Y, Renné T, Gerloff C, Huber S, Magnus T, Gelderblom M
J NEUROINFLAMM. 2021;18(1):.

2018

IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke
Zhang S, Piepke M, Chu H, Broughton B, Shim R, Wong C, Lee S, Evans M, Vinh A, Sakkal S, Arumugam T, Magnus T, Huber S, Gelderblom M, Drummond G, Sobey C, Kim H
JCI INSIGHT. 2018;3(18):.

Letzte Aktualisierung aus dem FIS: 20.12.2024 - 23:33 Uhr